UW Team Completes Large-scale Proteomic Analysis of Triple Negative Breast Cancer | GenomeWeb

NEW YORK (GenomeWeb) – Researchers at the University of Washington have completed an in-depth proteomic analysis of triple-negative breast cancer (TNBC).

Looking at 20 human derived breast cancer cell lines and four patient tumor samples, the study, which was detailed in a paper published today in Cell Reports, identified a variety of protein-defined breast cancer subtypes as well as potential therapeutic targets.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.